Beijing Choice Electronic Technology Co., Ltd., a Chinese manufacturer of patient monitoring devices, filed suit on January 31, 2018 in the Northern District of Illinois against Contec Medical Systems USA, Inc. and its Chinese parent Contec Medical Systems Co., Ltd. The complaint alleged infringement of US8639308B2, a patent directed to fingertip pulse oximeter technology. Contec’s accused products included six named CMS50-series models — CMS50D, CMS50D+, CMS50E, CMS50H, CMS50N, and CMS50QB — as well as OEM-equivalent pulse oximeters, suggesting a broad commercialisation dispute between two competing device manufacturers.

The case closed on January 7, 2025 on the basis of a parties’ stipulation and settlement, with Judge Franklin U. Valderrama entering a dismissal without prejudice. Critically, the order includes a conditional conversion clause: if neither party files a motion to reinstate by December 31, 2025, the dismissal automatically converts to a dismissal with prejudice — permanently barring re-litigation on the same claims. This structure is consistent with settlements requiring a defined period to confirm performance of confidential terms before the dispute is fully extinguished.

The 2,533-day duration is notably protracted even by the standards of complex patent cases involving international parties, suggesting the litigation encountered substantial procedural complexity, likely including claim construction disputes, discovery challenges across US and Chinese entities, and possibly IPR or inter partes proceedings. The public record does not disclose financial terms, royalty rates, or licensing arrangements. The involvement of multiple law firms on both sides — including Cooley LLP and King & Spalding for defendants, and Finnegan Henderson for plaintiff — reflects the commercial significance both parties attached to the outcome.